The in vitro analysis of the coagulation mechanism of activated factor VII using thrombelastogram

被引:33
作者
Kawaguchi, C [1 ]
Takahashi, Y [1 ]
Hanesaka, Y [1 ]
Yoshioka, A [1 ]
机构
[1] Nara Med Univ Hosp, Div Neonatal Intens Care, Kashihara, Nara 6348522, Japan
关键词
recombinant activated factor VII thrombelastogram;
D O I
10.1055/s-0037-1613300
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated the effects of addition of recombinant activated coagulation factor VII (rFVIIa) to coagulation factor-deficient plasma and whole blood, using thrombelastograms (TEGs). The addition of rFVIIa to factor II- or X-deficient plasma did not correct hemostatic parameters, whereas it produced partial responses in factor V, VIII- or IX-deficient plasma and good responses in factor VII-, XI- or XII-deficient plasma. Furthermore, the addition of rFVIIa and platelets (30-100 X 10(3)/mul) to platelet-poor plasma produced marked corrections, producing TEGs similar to those of platelet-rich plasma. These results indicate that factors II and X are essential for the hemostatic effects of rFVIIa, and that factors V and VIII promote these effects. We believe that TEGs are, at present, one of the most useful tools for evaluating in vitro hemostatic effects of rFVIIa.
引用
收藏
页码:768 / 772
页数:5
相关论文
共 20 条
[1]   LOSS OF MEMBRANE PHOSPHOLIPID ASYMMETRY IN PLATELETS AND RED-CELLS MAY BE ASSOCIATED WITH CALCIUM-INDUCED SHEDDING OF PLASMA-MEMBRANE AND INHIBITION OF AMINOPHOSPHOLIPID TRANSLOCASE [J].
COMFURIUS, P ;
SENDEN, JMG ;
TILLY, RHJ ;
SCHROIT, AJ ;
BEVERS, EM ;
ZWAAL, RFA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1026 (02) :153-160
[2]   The effect of the administration of recombinant activated factor VII (NovoSeven®) on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy:: the PROSE study [J].
Friederich, PW ;
Geerdink, MGF ;
Spataro, M ;
Messelink, EJ ;
Henny, CP ;
Büller, HR ;
Levi, M .
BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 :S129-S132
[3]   LABORATORY EVIDENCE OF DIC UNDER FEIBA TREATMENT OF A HEMOPHILIC PATIENT WITH INTRA-CRANICAL BLEEDING AND HIGH TITER FACTOR-VIII INHIBITOR [J].
FUKUI, H ;
FUJIMURA, Y ;
TAKAHASHI, Y ;
MIKAMI, S ;
YOSHIOKA, A .
THROMBOSIS RESEARCH, 1981, 22 (1-2) :177-184
[4]  
GILBERT GE, 1991, J BIOL CHEM, V266, P17261
[5]   MANAGEMENT OF HEMOPHILIA PATIENTS WITH INHIBITORS [J].
HEDNER, U ;
GLAZER, S .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (05) :1035-1046
[6]  
Hedner U, 1996, HAEMOSTASIS, V26, P102
[7]   The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis [J].
Hoffman, M ;
Monroe, DM .
SEMINARS IN HEMATOLOGY, 2001, 38 (04) :6-9
[8]  
Kristensen J, 1996, HAEMOSTASIS, V26, P159
[9]   Clinical experience with recombinant factor VIIa [J].
Lusher, J ;
Ingerslev, J ;
Roberts, H ;
Hedner, U .
BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (02) :119-128
[10]   The factor VII-Platelet interplay: Effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia [J].
Monroe, DM ;
Hoffman, M ;
Allen, GA ;
Roberts, HR .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (04) :373-377